Company / EPS (Diluted)
AbCellera Biologics Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.51
FY2025
5-year range
-$0.51 / $0.50
FY2021-FY2025
Trend
-202.0%
vs FY2024
Sector context
#70 of 204
Health Care
What the data says
EPS (Diluted) changed -202% YoY in FY2025, a notable deviation from the 6-year average annual change of +1484%.
Based on SEC 10-K filings.
-0.51 in FY2025.
Declined from $0.48 to $-0.51 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#70 of 204 in Health CareTop 34% of 204This company -$0.51 Sector average -$0.98
▼
+47.9% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 202.0% year-over-year.
- Ranks #70 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.51 | -202.0% |
| FY2024 | $0.50 | +4.2% |
| FY2023 | $0.48 | +6.7% |
| FY2022 | $0.45 | +4600.0% |
| FY2021 | -$0.01 | -102.2% |
| FY2020 | $0.45 | +4600.0% |
| FY2019 | -$0.01 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026